#rituximab

icon subthematics
Dubois  Lupus Erythematosus and Related Syndromes E-Book
Category

Ebooks

Dubois' Lupus Erythematosus and Related Syndromes E-Book

Daniel Wallace, Bevra Hannahs Hahn

Dubois  Lupus Erythematosus and Related Syndromes E-Book Alternate Text
Category

Ebooks

Medecine

Dubois' Lupus Erythematosus and Related Syndromes E-Book

Daniel Wallace, Bevra Hannahs Hahn

Book

1515 pages

Flag

English

Targeted Treatment of the Rheumatic Diseases E-Book
Category

Ebooks

Targeted Treatment of the Rheumatic Diseases E-Book

Ronald Van Vollenhoven, Michael H. Weisman, Michael E. Weinblatt, James S. Louie

Targeted Treatment of the Rheumatic Diseases E-Book Alternate Text
Category

Ebooks

Medecine

Targeted Treatment of the Rheumatic Diseases E-Book

Ronald Van Vollenhoven, Michael H. Weisman, Michael E. Weinblatt, James S. Louie

Book

924 pages

Flag

English

Comprehensive Dermatologic Drug Therapy E-Book
Category

Ebooks

Comprehensive Dermatologic Drug Therapy E-Book

Jashin J. Wu

Comprehensive Dermatologic Drug Therapy E-Book Alternate Text
Category

Ebooks

Medecine

Comprehensive Dermatologic Drug Therapy E-Book

Jashin J. Wu

Book

1626 pages

Flag

English

Bortezomib plus rituximab versus rituximab in patients with high-risk, relapsed, rituximab-naïve or rituximab-sensitive follicular lymphoma: subgroup analysis of a randomized phase 3 trial
Category

Documents

Bortezomib plus rituximab versus rituximab in patients with high-risk, relapsed, rituximab-naïve or rituximab-sensitive follicular lymphoma: subgroup analysis of a randomized phase 3 trial

Elsayed, Zinzani Pier, Khuageva, Wang Huaqing, Garicochea Bernardo, Walewski Jan, Van, Caballero Dolores, Buckstein Rena, Esseltine Dixie-Lee, Theocharous Panteli, Enny Christopher, Zhu Eugene, Coiffier Bertrand, Pierre Soubeyran

Bortezomib plus rituximab versus rituximab in patients with high-risk, relapsed, rituximab-naïve or rituximab-sensitive follicular lymphoma: subgroup analysis of a randomized phase 3 trial Alternate Text
Category

Documents

Savoirs

Bortezomib plus rituximab versus rituximab in patients with high-risk, relapsed, rituximab-naïve or rituximab-sensitive follicular lymphoma: subgroup analysis of a randomized phase 3 trial

Elsayed, Zinzani Pier, Khuageva, Wang Huaqing, Garicochea Bernardo, Walewski Jan, Van, Caballero Dolores, Buckstein Rena, Esseltine Dixie-Lee, Theocharous Panteli, Enny Christopher, Zhu Eugene, Coiffier Bertrand, Pierre Soubeyran

Book

10 pages

Flag

English

ANÁLISIS COSTE-EFECTIVIDAD DELTRATAMIENTO DE MANTENIMIENTO CON RITUXIMAB EN PACIENTES CON LINFOMAFOLICULAR QUE RESPONDEN A LA TERAPIA DE INDUCCIÓN EN PRIMERA LÍNEA (Cost-Effectiveness Analysis of Maintenance Therapy with Rituximab in Patients with Follicular Lymphoma Responding toInduction Therapy at the First Line)
Category

Documents

ANÁLISIS COSTE-EFECTIVIDAD DELTRATAMIENTO DE MANTENIMIENTO CON RITUXIMAB EN PACIENTES CON LINFOMAFOLICULAR QUE RESPONDEN A LA TERAPIA DE INDUCCIÓN EN PRIMERA LÍNEA (Cost-Effectiveness Analysis of Maintenance Therapy with Rituximab in Patients with Follicular Lymphoma Responding toInduction Therapy at the First Line)

Antonio

ANÁLISIS COSTE-EFECTIVIDAD DELTRATAMIENTO DE MANTENIMIENTO CON RITUXIMAB EN PACIENTES CON LINFOMAFOLICULAR QUE RESPONDEN A LA TERAPIA DE INDUCCIÓN EN PRIMERA LÍNEA (Cost-Effectiveness Analysis of Maintenance Therapy with Rituximab in Patients with Follicular Lymphoma Responding toInduction Therapy at the First Line) Alternate Text
Category

Documents

Autres

ANÁLISIS COSTE-EFECTIVIDAD DELTRATAMIENTO DE MANTENIMIENTO CON RITUXIMAB EN PACIENTES CON LINFOMAFOLICULAR QUE RESPONDEN A LA TERAPIA DE INDUCCIÓN EN PRIMERA LÍNEA (Cost-Effectiveness Analysis of Maintenance Therapy with Rituximab in Patients with Follicular Lymphoma Responding toInduction Therapy at the First Line)

Antonio

Book

14 pages

Flag

Español

  • 1
Alternate Text